<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1122490742015118&amp;ev=PageView&amp;noscript=1">

The REVERSE Study - Stage II Chronic Kidney Disease (CKD) In Cats

CLOSED FOR RECRUITMENT

Evidence exists to suggest that aging of the kidney may contribute to the onset and progression of chronic kidney disease (CKD). mTOR inhibition is a known modulator of the aging process and additionally may decrease the formation of fibrosis (scarring) in the kidney. The purpose of this study is to assess the potential benefits of dosing TRIV307 in cats with Stage II CKD. 

REVERSE Study Graphic

Register Interest For Future Trials!

We invite you to be a part of something truly meaningful - a pharmaceutical trial that has the potential to improve the lives of pets worldwide. By registering your beloved furry companion for our trial, you are taking a step towards a brighter and healthier future for them and countless other animals.

Fill In Your Details Here 👇

Free Downloads

The Ohio State University REVERSE Study Flyer Smaller Mockup

REVERSE Study Flyer (The Ohio State University College Of Veterinary Medicine)

University Of Florida REVERSE Study Flyer Smaller Mockup

REVERSE Study Flyer (University Of Florida College Of Veterinary Medicine)